• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    RedChip CEO Dave Gentry Invited to Join Forbes Business Council

    1/25/23 8:00:00 AM ET
    $AREC
    $BIVI
    $GNS
    $RVPH
    Coal Mining
    Energy
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AREC alert in real time by email

    ORLANDO, FL / ACCESSWIRE / January 25, 2023 / RedChip Companies is pleased to announce its CEO, Dave Gentry, was recently welcomed as a member of the Forbes Business Council.

    The Forbes Business Council committee invited Gentry to join the elite group of business leaders in recognition of his passion for helping entrepreneurs achieve success. The invitation-only community is made up of successful business owners and executives who have been chosen based on their accomplishments and experience.

    As a member, Gentry will be able to leverage the Forbes Business Council's collective resources to help foster growth in the RedChip Companies community. He will also be able to participate in exclusive events, such as invite-only webinars and podcasts, publish expert insights as a contributing writer on the Forbes platform, access a private community of members, and more.

    Gentry commented, "I look forward to sharing insights gained from my decades of experience working with executives in the small-cap markets. I believe this is a great opportunity to enhance my contributions to the entrepreneurial spirit that drives business innovations globally, while also gaining valuable new insights from industry veterans."

    Gentry is the author of Small Stocks, Big Money, a Wiley-published book of interviews with the world's most successful small-cap investors. He has been a consultant to more than 1,000 public companies and assisted dozens of public companies in the up-listing and capital-raising process. In 2012 he founded The RedChip Money Report™, a weekly cable TV financial news show broadcast in 177 million homes. He has appeared on CNBC and Fox Business News and is widely known as a thought leader in the small-cap space.

    Gentry has been a presenter at the New York Society of Security Analysts, Deal Flow Media conferences, and other small-cap conferences, and he has rung the NASDAQ bell on three occasions. In 2011, he was honored by Inc. Magazine as CEO of one of the fastest-growing private companies in America. In 1996, he won the Republican nomination in the 5th District of Florida for the United States House of Representatives. In 1994 he co-founded the First Amendment Coalition, an independent, nonprofit, collegiate-based student organization, and received national and international attention for his work defending free speech on college campuses. Gentry's activism led to his book 100+ Cases of Campus Censorship, published by David Horowitz's Second Thoughts Books. Gentry earned his Master of Education from the University of Florida in 1993.

    RedChip currently represents more than 70 clients, including some of the best emerging growth companies in the small-cap space, such as Genius Group (NYSE:GNS), Reviva Pharmaceuticals (NASDAQ:RVPH), Zomedica (NYSE:ZOM), BioVie (NASDAQ:BIVI), and American Resources Corporation (NASDAQ:AREC).

    About Forbes Business Council

    The Forbes Business Council is an exclusive platform that brings together successful business owners and executives from all over the world. Members are handpicked by the Forbes Business Council committee based on their accomplishments, experience, and commitment to helping entrepreneurs reach their goals.

    About RedChip Companies

    RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 30 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, the RedChip Money Report is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, "The RedChip Money Report," which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.

    To learn more about RedChip's products and services, please visit:

    https://www.redchip.com/corporate/investor_relations

    "Discovering Tomorrow's Blue Chips Today"™

    Contact:

    Matt Sheldon
    RedChip Companies Inc.
    1-800-RED-CHIP (733-2447)
    [email protected]

    SOURCE: RedChip



    View source version on accesswire.com:
    https://www.accesswire.com/736680/RedChip-CEO-Dave-Gentry-Invited-to-Join-Forbes-Business-Council

    Get the next $AREC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AREC
    $BIVI
    $GNS
    $RVPH

    CompanyDatePrice TargetRatingAnalyst
    American Resources Corporation
    $AREC
    11/26/2025$7.00Buy
    Maxim Group
    American Resources Corporation
    $AREC
    10/20/2025Outperform
    William Blair
    Reviva Pharmaceuticals Holdings Inc.
    $RVPH
    9/29/2025$2.00Buy
    Chardan Capital Markets
    American Resources Corporation
    $AREC
    9/15/2025$6.00Buy
    D. Boral Capital
    Reviva Pharmaceuticals Holdings Inc.
    $RVPH
    9/20/2023$12.00Buy
    ROTH MKM
    Reviva Pharmaceuticals Holdings Inc.
    $RVPH
    6/8/2023$17.00Speculative Buy
    The Benchmark Company
    Zomedica Corp.
    $ZOM
    1/6/2023$6.00Buy
    Dawson James
    BioVie Inc.
    $BIVI
    7/22/2022$7.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $AREC
    $BIVI
    $GNS
    $RVPH
    SEC Filings

    View All

    Reviva Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Filer)

    12/23/25 8:05:14 AM ET
    $RVPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by Reviva Pharmaceuticals Holdings Inc.

    SCHEDULE 13D/A - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Subject)

    12/22/25 4:30:05 PM ET
    $RVPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 25-NSE filed by Reviva Pharmaceuticals Holdings Inc.

    25-NSE - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Subject)

    12/12/25 4:53:15 PM ET
    $RVPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AREC
    $BIVI
    $GNS
    $RVPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Medical Officer Palumbo Joseph M

    4 - BIOVIE INC. (0001580149) (Issuer)

    1/9/26 5:03:29 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Financial Officer Kim Joanne Wendy

    4 - BIOVIE INC. (0001580149) (Issuer)

    1/9/26 5:03:04 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Rogich Sigmund

    4 - BIOVIE INC. (0001580149) (Issuer)

    1/9/26 5:02:46 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AREC
    $BIVI
    $GNS
    $RVPH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The $587B Strategic Surge: Why China's Export Ban is Scaling a North American Metal Boom

    Issued on behalf of GoldHaven Resources Corp. VANCOUVER, BC, Jan. 14, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – The global critical minerals market is on a collision course with reality, projected to explode from $328 billion to a staggering $587 billion by 2032[1]. As China tightens its "Resource Iron Curtain" by weaponizing supply chains and restricting exports for silver, tungsten, and antimony, the West is facing a critical vulnerability in defense and semiconductor procurement[1]. This high-stakes rotation into secure, proprietary strategic metal platforms is fueling the 2026 investment case for GoldHaven Resources (CSE:GOH) (OTCQB:GHVNF), American Tungsten (CSE:TUNG) (OTC

    1/14/26 9:15:00 AM ET
    $AREC
    Coal Mining
    Energy

    Genius Group Sets ERL Share Count Date for February 13, 2026

    Share Count Exercise designed to resolve discrepancy on 68% of GNS shares reportedly held by brokers at time of ERL spinoff. SINGAPORE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group", "GNS" or the "Company"), a leading AI-powered, Bitcoin-first education group, today announced that it has set a share count date for February 13, 2026, related to Genius Group shares associated with the Company's Asset Purchase Agreement ("APA") with Entrepreneur Resorts Ltd ("ERL"). The Company believes that the Share Count will have a positive impact for current Genius Group shareholders and ERL shareholders for the following two reasons: Resolution of the 68% discrepan

    1/12/26 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson's Disease

    - Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone - - Topline Results from the SUNRISE-PD Trial Expected in 1H 2026 - CARSON CITY, Nev., Jan. 08, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced that it has completed enrollment of 60 patients in its Phase 2 SUNRISE-PD clinical trial evaluating the safety and efficacy of bezisterim (NE3107) on motor and non-motor symptoms in individuals with early-stage Parkinson's disease (PD) who have not been treated with

    1/8/26 8:00:00 AM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AREC
    $BIVI
    $GNS
    $RVPH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on American Resources Corp. with a new price target

    Maxim Group initiated coverage of American Resources Corp. with a rating of Buy and set a new price target of $7.00

    11/26/25 7:50:43 AM ET
    $AREC
    Coal Mining
    Energy

    William Blair initiated coverage on American Resources Corp.

    William Blair initiated coverage of American Resources Corp. with a rating of Outperform

    10/20/25 8:43:21 AM ET
    $AREC
    Coal Mining
    Energy

    Chardan Capital Markets initiated coverage on Reviva Pharmaceuticals with a new price target

    Chardan Capital Markets initiated coverage of Reviva Pharmaceuticals with a rating of Buy and set a new price target of $2.00

    9/29/25 9:59:06 AM ET
    $RVPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AREC
    $BIVI
    $GNS
    $RVPH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Golden Properties Ltd. decreased direct ownership by 7% to 12,389,960 units (SEC Form 4)

    4 - American Resources Corp (0001590715) (Issuer)

    8/20/25 12:33:35 PM ET
    $AREC
    Coal Mining
    Energy

    President & CEO Do Cuong V bought 5,000 shares (SEC Form 4)

    4 - BIOVIE INC. (0001580149) (Issuer)

    8/13/25 4:05:17 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Golden Properties Ltd. decreased direct ownership by 7% to 13,389,960 units (SEC Form 4)

    4 - American Resources Corp (0001590715) (Issuer)

    8/1/25 1:26:00 PM ET
    $AREC
    Coal Mining
    Energy

    $AREC
    $BIVI
    $GNS
    $RVPH
    Leadership Updates

    Live Leadership Updates

    View All

    Genius Group Engages DLA Piper as Advisor on Australian Securities Exchange (ASX) Dual Listing.

    SINGAPORE, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered, Bitcoin-first education group, today announced that it has appointed DLA Piper as advisor on the Company's application for a dual listing on Australian Securities Exchange (ASX). Following the Company's Board of Directors approval on August 8, 2025 to pursue a dual listing on an Asia Pacific exchange to enhance shareholder value and accessibility, the Company has been investigating potential stock exchanges, resulting in a shortlist of three exchanges in Australia (ASX), South Korea (KRX) and Hong Kong (HKEX). From the shortlist, the Company has selected t

    12/18/25 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Genius Group Announces New Analyst Report from Diamond Equity Research

    SINGAPORE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group", "GNS" or the "Company"), a leading AI-powered, Bitcoin-first education group, today announced the release of a new Analyst Update Report from Diamond Equity Research, an issuer sponsored equity research firm focused on small capitalization companies, covering Genius Group's common stock. Genius Group has worked with Diamond Equity Research to perform independent research that will create greater awareness and exposure in the investment community for the company's AI-powered education growth plans and Bitcoin Treasury strategy. Report Highlights Notable highlights from the report include: Broad

    11/24/25 8:30:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Diamond Equity Research Releases Update Note on Genius Group Ltd. (NYSE: GNS)

    New York, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an update note on Genius Group Ltd. (NYSE:GNS). The update note includes information on the Genius Group Ltd.' financial results, management commentary, recent developments, outlook, risks, and our revised valuation estimates. The research summary below is from a report commissioned by Genius Group Ltd. and produced by Diamond Equity Research. Investors can find various risk factors in the update report and in the respective financial filings for Genius Group Limited.  The full research report is available below. Genius Group Nove

    11/21/25 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AREC
    $BIVI
    $GNS
    $RVPH
    Financials

    Live finance-specific insights

    View All

    Genius Group Acquires Lighthouse Studios, to Launch Genius Studios.

    SINGAPORE, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered, Bitcoin-first education group, today announced that it acquired Lighthouse Studios, a podcast and video production studio for entrepreneurs, creators and influencers based in Singapore, on December 19, 2025 and plans to relaunch the studio as Genius Studios on January 23, 2026. Lighthouse Studios is a podcast and video production studio for entrepreneurs, creators and influencers based in Bali, Indonesia. The purpose built facility includes a variety of recording studios, co-working space, café and meeting rooms. Genius Group has acquired the company in an

    12/23/25 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Diamond Equity Research Releases Update Note on Genius Group Ltd. (NYSE: GNS)

    New York, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released update note on Genius Group Ltd. (NYSE: GNS). The update note includes information on the Genius Group Ltd.' financial results, management commentary, recent developments, outlook, risks, and our revised valuation estimates. The research summary below is from a report commissioned by Genius Group Ltd. and produced by Diamond Equity Research. Investors can find various risk factors in the update report and in the respective financial filings for Genius Group Limited. The update note is available below. Genius Group Update

    9/25/25 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Genius Group Announces 25% Increase in Revenue on proforma basis, 57% Decrease in Net Loss per Share in First Half of 2025

    Total assets increased 20% to $121.3 million SINGAPORE, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered, Bitcoin-first education group, today announced its financial results for the first half of 2025. Roger Hamilton, CEO of Genius Group, said "In the first half of 2025, Genius Group was hamstrung by a preliminary injunction preventing the company from raising funds or building its treasury. We have claimed in a RICO lawsuit (Case No: 1:25-cv-21496-BB) that this was a deliberate act taken by third parties to damage the company and its shareholders. We are pleased that further to the injunction being stayed on appe

    9/23/25 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AREC
    $BIVI
    $GNS
    $RVPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Genius Group Limited

    SC 13G - Genius Group Ltd (0001847806) (Subject)

    11/14/24 5:32:28 PM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Reviva Pharmaceuticals Holdings Inc.

    SC 13G/A - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Subject)

    11/14/24 5:16:56 PM ET
    $RVPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Reviva Pharmaceuticals Holdings Inc.

    SC 13G - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Subject)

    11/14/24 4:15:57 PM ET
    $RVPH
    Biotechnology: Pharmaceutical Preparations
    Health Care